Access to Information Requests Completed - November 2011

This content was archived on June 24, 2013.

The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)

If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.

Completed Requests

For the month of November 2011

Request #	Summary of Requests	Status of Completed Request	Number of Pages Disclosed
A-2009-00243	Information regarding the product Fibre & Weight Balance, NPN 80008031 by Naka Sales Ltd.	Disclosed in part	174
A-2009-00248	Information regarding the product Defense, NPN 80000907 by Nute-Life Nutrition Ltd.	Disclosed in part	189
A-2009-00469	Complete complaint history and post marketing communication of Twinject 0.3mg auto injector (DIN 02247310) and Twinject 0.15mg auto injector (DIN 02268205) by Paladin Laboratories Inc.	Disclosed in part	991
A-2009-00500	Documents related to appearance at Senate Committee on Aboriginal Peoples, by Associate Depupty Minister Anne-Marie Robinson, Michelle Kovacevic, and Shelagh Jane Woods on June 23, 2009.	Disclosed in part	194
A-2009-00951	All documents relating to the Regulations Amending the Marihuana Medical Access Regulations, SOR/2009-142.	Disclosed in part	240
A-2009-01246	All documents related to the Draft Guidance for Industry: Use of Metabolite Data in Comparative Bioavailability Studies.	Disclosed in part	47
A-2010-00058	Documents of all medical device problem reports to the Durom Acetabular Cup (also known as Durom Hip Resurfacing System - Acetabular Component) manufactured by Zimmer GMBH. (Jan 1, 2005 to Apr 13, 2010).	Disclosed in part	570
A-2010-00116	All documents about the Aamjiwnaang First Nation (Sarnia Band 45) related to the following: Funding a community health study Inter/trans-jurisdictional policy issues Proposed shell refinery Pollution and contaminants on the reserve and/or in the St. Clair River. (Jan 1, 2005 to Apr 29, 2010)	Disclosed in part	629
A-2010-00488	All minutes of Toy Committee meetings from May 23, 2009 to July 7, 2010.	Disclosed in part	53
A-2010-00730	Documents related to the safety and efficacy for the following NPNs: 80000219, 80007496, 80015861, 80014075, 80005852, 80019324, 01965158, 80005012, 80012308, 00876119, 80005218, 80012390, 80005068, 80004876 and 00257044.	Disclosed in part	506
A-2010-00768	All written communications with media relations officer Gary Holub and members of that same department related to TV/radio interview requests from the media about Health Canada's involvement with the Truth and Reconciliation Commission held in Winnipeg in June of 2010. (Jun 1, 2010 to Oct 15, 2010).	Disclosed in part	399
A-2010-00878	Correspondence by Dr. Yvette Bonvalot and/or Dr. Pierre Band suggesting that all residents of Valcartier and Shannon be tested for contaminants; and a report on waterborne contaminants in the Valcartier/Shannon groundwater.	No records exist	0
A-2010-01045	All documents related to tobacco warning labels renewal toll free quit line going on hold and the Minister's decision to take a step back to evaluate. (Sep 1, 2009 to Jan 10, 2011).	Disclosed in part	352
A-2010-01159	List of correspondence and emails related to tobacco to and from the Minister's office.  (Sep 1, 2010 to Jan 14, 2011)	Disclosed in part	22
A-2010-01160	List of visitors to the Minister's office related to tobacco. Jan 10, 2011 to Jan 14, 2011).	All disclosed	1
A-2010-01193	All documents from 2010 relating to the Strategic Policy Branch's "monitoring framework to support the accountable management of the Infoway funding agreements".	All disclosed	76
A-2010-01279	Information regarding the product Wellbutrin SR by GlaxoSmithKline.	Disclosed in part	280
A-2010-01312	All final pharmacovigilance reports or post-approval assessments regarding risk and safety submitted by GlaxoSmithKline or created by Health Canada regarding the vaccine Arepanrix H1N1. (Sep 1, 2009 to Feb 15, 2011).	Disclosed in part	2,330
A-2010-01487	Information regarding the risk assessment related to (Chrysotile) Asbestos.	Disclosed in part	121
A-2010-01557	Information regarding the product Clindamycin Injection USP, DINs 02230535 and 02230540 by Sandoz Canada Inc.	Disclosed in part	304
A-2010-01559	Information regarding the product Clindamycin Phosphate Injection USP, DIN 02130866 by Abbott Laboratories Ltd.	Disclosed in part	202
A-2011-00061	Information regarding the product Nasonex (mometasone furoate).	Disclosed in part	173
A-2011-00063	All documents on the issue of opioid analgesic abuse. (Apr 13, 2010 to Apr 12, 2011).	Disclosed in part	676
A-2011-00073	Information regarding the product ACETAMINOPHEN 500 MG TABLETS EXTRA STRENGTH EASY TO SWALLOW, DIN 02255251 by Pharmetics Inc.	Disclosed in part	22
A-2011-00074	Information regarding the product CREST PRO-HEALTH COMPLETE, NPN 80015160.	Disclosed in part	120
A-2011-00113	Information regarding the product Nasal decongestant spray with moisturizer, DIN 02241736.	Disclosed in part	21
A-2011-00114	Information regarding the product Lotion sport, DIN 02290103.	Disclosed in part	36
A-2011-00115	Information regarding the product Crème écran solaire, DIN 02262002.	Disclosed in part	45
A-2011-00186	AERs. Report numbers: 000208863, 000207379, 000207571, 000207607, 000207796, 000207848, 000208169, 000208170, 000208659 and 000208685.	Disclosed in part	31
A-2011-00190	AERs. Report numbers: 000197347, 000197405, 000197451, 000197989, 000198146, 000198347, 000198966, 000198972, 000198974 and 000198976.	Disclosed in part	72
A-2011-00252	The current funding agreement with Canada Health Infoway Inc.	All disclosed	144
A-2011-00321	AERs for the product Tylenol. Report numbers: 000121772, 000126192, 000126368, 000129043, 000131520, 000137573, 000138272, 000140604, 000142556 and 000142557.	Disclosed in part	32
A-2011-00322	All documents in MECS for the following files: 09-009284-482, 09-136985-149, 09-134990-692 and 10-102250-201.	Disclosed in part	103
A-2011-00326	All documents in MECS for the following files: 10-110582-700, 10-111477-287, 10-110590-991, 10-112142-50, 10-111999-93 and 10-000249-664.	Disclosed in part	389
A-2011-00329	All documents in MECS for the following files: 10-117995-709, 10-122105-772, 10-005417-870, 10-122598-166, 10-122533-390, 10-122050-771 and 10-124380-514.	Disclosed in part	233
A-2011-00331	All documents in MECS for the following files: 10-113766-950, 10-114117-315, 10-113394-882, 10-120423-800, 10-006850-925 and 10-125812-926.	Disclosed in part	177
A-2011-00353	A copy of agendas, minutes and supporting documents for Health Canada's Food Directorate/Natural Health Products Directorate Working Group. (Jan 1 2010 to Jun 30 2010).	Disclosed in part	2
A-2011-00363	AER for the product Aspirin. Report number: 000364759.	Disclosed in part	6
A-2011-00378	All documents showing the number of medical-marijuana licence holders found to be in non-compliance with federal regulations. (Jun 29, 2008 to Jun 30, 2011).	Disclosed in part	316
A-2011-00384	All emails at Health Canada headquarters at Director General level or higher about the Rotterdam Convention conference June 20-24, 2011 and chrysotle asbestos. (Mar 1, 2011 to Jun 27, 2011).	Disclosed in part	20
A-2011-00409	All documents in MECS for the following files: 11-100539-874 and 10-112827-31.	Disclosed in part	20
A-2011-00458	Health Canada's financial agreement (grant) between the Canadian Partnership Against Cancer, 2007 and 2009.	Disclosed in part	181
A-2011-00490	AER for the product Synthroid. Report number: 000356329.	Disclosed in part	1
A-2011-00492	Information regarding the product Genestra Brands Tads, NPN 80023321.	Disclosed in part	137
A-2011-00510	All briefing materials provided to the minister or deputy minister to inform the decision announced June 29, 2011, to fund the Multiple Sclerosis treatment known as the Liberation therapy in clinical trials.	All disclosed	66
A-2011-00522	Information regarding the product Stuffy Nose & Cough, NPN 80025739.	Disclosed in part	54
A-2011-00590	All documents regarding every tobacco manufacturer and importer that reported that it promoted a product other than an accessory with a consumer tobacco product-related brand element. (Jan 1, 2010 to Jun 30, 2011).	No records exist	0
A-2011-00599	All documents relating to requests for removal of content from Google services. (Jul 1, 2009 to Jul 26, 2011).	No records exist	0
A-2011-00618	List of individual non statutory Grants and Contribution Claim submissions in 2008/09, 2009/10 and 2010/11.	All disclosed	8,475
A-2011-00637	The most recent draft version of the guidelines entitled: Canadian Guidelines for Wind Turbine Noise Working Group of the Federal/Provincial/Territorial Committee on Health and the Environment.	Disclosed in part	47
A-2011-00650	All documents related to an analysis or summary done by the Privy Council Office of the results of a telephone survey that evaluated the 2010-11 Children's Health and Safety Marketing campaign led by Health Canada.	Disclosed in part	302
A-2011-00669	All documents regarding Counterfeit Drugs related to imports. (Jan 1, 2010 to Dec 31, 2010).	Disclosed in part	7
A-2011-00690	All documents in 'Biotechnology 2' section about AquAdvantage salmon by AquaBounty Technologies. (Jan 1, 2011 to Sep 6, 2011).	Disclosed in part	27
A-2011-00713	AERs for the product Avelox. Report numbers: 000368734, 000368810, 000369342, 000369726 and 000369771.	Disclosed in part	7
A-2011-00714	AERs for the product Yaz. Report numbers: 000368441, 000368853 and 000369463.	Disclosed in part	7
A-2011-00715	AERs for the product Yasmin. Report numbers: 000367680 and 000368441.	Disclosed in part	2
A-2011-00716	AER for the product Xarelto. Report number: 000369303.	Disclosed in part	1
A-2011-00717	AERs for the product Mirena. Report numbers: 000367844, 000368547, 000369038, 000369749 et 000369810.	Disclosed in part	7
A-2011-00718	AER for the product Magnevist. Report number: 000368852.	Disclosed in part	2
A-2011-00719	AER for the product Diane 35. Report number: 000368805.	Disclosed in part	1
A-2011-00720	AER for the product Cipro. Report number: 000368578.	Disclosed in part	1
A-2011-00737	Information regarding the product Strepsils Sore Throat Blocked Nose, DIN 02238543.	All disclosed	29
A-2011-00750	All drafts and revision notes for any updates to the media relations and communications policy manual for the years 2008, 2010 and 2011. Including the media relations and communications policy manual for the year 2000 and 2011.	All disclosed	68
A-2011-00754	Minutes from the following meetings that has any connection to the dairy industry: Meetings held in the first two weeks of April 2006 in St.John's, Halifax, Montreal, Toronto, Winnipeg, Regina, Calgary, and Vancouver for stakeholders in the revision of Canada's Food Guide.	Disclosed in part	222
A-2011-00756	All call-ups processed by this institution in the National Capital Region under the terms of the ANY Standing Offer or Supply Arrangement for Temporary Help Services during the period of September 2011.	Disclosed in part	75
A-2011-00761	All information pertaining to medical device reports involving 27 gauge dental needles. (Jan 1, 2001 to Oct 12, 2011).	Disclosed in part	1
A-2011-00766	Costs of document development for the latest version of Canada's Food Guide. (Jan 1, 2001 to Feb 5, 2007).	All disclosed	1
A-2011-00782	All reports of medication errors reported to Health Canada by health care professionals, the public or any other organization since June 2008, due to the confusion of Pradax and Plavix (clopidogrel).	Disclosed in part	24
A-2011-00796	Documents submitted by BASF in support of their application known as CLB-1 for herbicide tolerant canola.	No records exist	0
A-2011-00799	Information regarding the product MODAFINIL, DIN 02285398 by Apotex Inc.	All disclosed	40
A-2011-00803	The supporting reviews indicated in the communication signed by Jacques Bouchard (Director, Biologics and Genetic Therapies Directorate), which are referenced as providing the basis of the request to update the product monograph for proton pump inhibitors.	Disclosed in part	124
A-2011-00820	AER for the product Synagis AR. Report number: 000360260.	Disclosed in part	2
A-2011-00825	AER for the product Abraxane (028-21660-11101704).	No records exist	0
A-2011-00829	Documents regarding the financial statements published in the Public Accounts of Canada 2009-2010.	All disclosed	2
A-2011-00840	All the documents to and from the minster regarding the health impacts or risk of water contamination on residents from the Athabasca Oil Sands, Cold Lake Oil Sands, and Peace River Oil Sands. (Mar 24, 2011 to Oct 20, 2011).	No records exist	0
A-2011-00843	Documents on all prohibited cosmetic products in Canada containing more than 65 parts per million of mercury as the metal. (Jan 1, 2011 to Oct 20, 2011).	No records exist	0
A-2011-00846	AERs for the product Tubersol. Report numbers: 000343236, 000349307, 000353787, 000353788, 000354529, 000355738, 000357683, 000357684, and 000348589.	Disclosed in part	20
A-2011-00847	Number of SAP releases for the following drug for the months of June, July, August and September 2011: Afatinib.	All disclosed	1
A-2011-00848	Number of SAP releases for the following drug for the months of June, July, August and September 2011: Belinostat.	No records exist	0
A-2011-00849	Number of SAP releases for the following drug for the months of June, July, August and September 2011: Bendamustine.	All disclosed	1
A-2011-00850	Number of SAP releases for the following drug for the months of June, July, August and September 2011: Cabazitaxel (Jevtana).	All disclosed	1
A-2011-00851	Number of SAP releases for the following drug for the months of January to September 2011: Campath.	No records exist	0
A-2011-00852	Number of SAP releases for the following drug for the months of June to September 2011: Carfilzomib.	No records exist	0
A-2011-00853	Number of SAP releases for the following drug for the months of June to September 2011: Dacogen (Decitabine).	No records exist	0
A-2011-00854	Number of SAP releases for the following drug for the months of January to September 2011: Feraheme.	No records exist	0
A-2011-00855	Number of SAP releases for the following drug for the months of June to September 2011: Folotyn (Pralatrexate).	No records exist	0
A-2011-00856	Number of SAP releases for the following drug for the months of June to September 2011: Halaven (Eribulin Mesylate).	All disclosed	1
A-2011-00857	Number of SAP releases for the following drug for the months of June to September 2011: Prochymal (Remestemcel-L).	No records exist	0
A-2011-00858	Number of SAP releases for the following drug for the months of June to September 2011: Targretin (Bexaretene).	No records exist	0
A-2011-00859	Number of SAP releases for the following drug for the months of May to September 2011: Treanda (Bendamustine).	All disclosed	1
A-2011-00860	Number of SAP releases for the following drug for the months of January to September 2011: Velcade.	No records exist	0
A-2011-00861	Number of SAP releases for the following drug for the months of January to September 2011: Zolinza.	No records exist	0
A-2011-00866	AERs for the medical device One Touch Blood Glucose Meters. License numbers: 31552.	All disclosed	2
A-2011-00867	Medical Device Mandatory Problem Reports for Accu Chek Blood Glucose Meters (Licence No: 2688) received at Health Canada from Oct 1, 2010 to Sep 30, 2011.	All disclosed	2
A-2011-00868	All call-ups awarded in the Pacific Region and in the Ontario Region (Toronto) for Temporary Help Services during 2011.	Disclosed in part	371
A-2011-00871	List of completed investigations that involved Health Canada employees on alleged wrongdoings. (Jan 1, 2006 to Oct 24, 2011).	All disclosed	2
A-2011-00890	All documents regarding the International Narcotics Control Board (INCB) concerning the January 2010 earthquake in Haiti. (January to March 2010).	All disclosed	3
A-2011-00898	AERs for the product Cipralex. Report numbers: 000365530, 000365807, 000366129, 000367105, 000370057, 000370104, 000371773 and 000372773.	Disclosed in part	11
A-2011-00902	All documents related to Institute of Medicine's 'front-of-package' Phase 2 report. (Oct 1, 2011 to Oct 28. 2011).	No records exist	0
A-2011-00904	All documents related to the Healthy Foods Working Group. (Feb 11, 2011 to Oct 27, 2011).	No records exist	0
A-2011-00911	All TBIPS contracts awarded in 2011 by Public Works and Government Services Canada in the National Capital Region.	Disclosed in part	7
A-2011-00912	All TSPS contracts awarded in 2011 by Public Works and Government Services Canada in the National Capital Region.	No records exist	0
A-2011-00916	AER for the product Celexa. Report number: 000369378.	Disclosed in part	1
A-2011-00917	AER for the product Clopixol. Report number: 000368468.	Disclosed in part	1
A-2011-00918	AER for the product Ebixa. Report number: 000370451.	Disclosed in part	1
A-2011-00929	Request for the DIN number for the product BENDAMUSTINE.	No records exist	0
A-2011-00931	Number of SAP releases for the following drug for the month of October 2011: Treanda.	All disclosed	1
A-2011-00932	Number of SAP releases for the following drug for the month of October 2011: Targretin.	No records exist	0
A-2011-00933	Number of SAP releases for the following drug for the month of October 2011: Dacogen.	All disclosed	1
A-2011-00934	Number of SAP releases for the following drug for the month of October 2011: Carfilzomib.	No records exist	0
A-2011-00935	Number of SAP releases for the following drug for the month of October 2011: Folotyn.	No records exist	0
A-2011-00936	Number of SAP releases for the following drug for the month of October 2011: Zolinza.	No records exist	0
A-2011-00938	Number of SAP releases for the following drug for the month of October 2011: Prochymal.	No records exist	0
A-2011-00939	Number of SAP releases for the following drug for the month of October 2011: Halaven.	No records exist	0
A-2011-00940	Number of SAP releases for the following drug for the month of October 2011: Cabazitaxel.	No records exist	0
A-2011-00941	Number of SAP releases for the following drug for the month of October 2011: Belinostat.	No records exist	0
A-2011-00942	Number of SAP releases for the following drug for the month of October 2011: Campath.	No records exist	0
A-2011-00943	Number of SAP releases for the following drug for the month of October 2011: Feraheme.	No records exist	0
A-2011-00944	Number of SAP releases for the following drug for the month of October 2011: Velcade.	No records exist	0
A-2011-00949	All call-ups and amendments issued under the terms of the TBIPS Standing Offer (EN578-055605) in the National Capital Region during the month of October 2011.	No records exist	0
A-2011-00967	AERs for the product Cymbalta. Report numbers: 000367660, 000369865 and 000371762.	Disclosed in part	8
A-2011-00969	AER for the product Evista. Report number: 000366567.	Disclosed in part	1
A-2011-00981	Information regarding clinical trials for the product Adcetris (formerly 'SGN-35').	No records exist	0
A-2011-01016	Previously released request A-2008-00690: Information regarding the products COLD FX, Cell-fx, Menta-fx, Pressure-fx, Remember-fx by CV Technologies Inc.	Disclosed in part	30
A-2011-01018	Previously released request A-2007-00237: Information regarding the product COLD FX, NPN 800002849 by CV Technologies Inc.	Disclosed in part	303
A-2011-01019	Previously released request A-2007-00010: Information regarding the product COLD FX.	Disclosed in part	114
A-2011-01020	Previously released request A-2006-00586: Information regarding the products COLD FX, CELL-FX, MENTA-FX, PRESSURE-FX, REMEMBER-FX by CV Technologies.	No records exist	0
A-2011-01043	Number of SAP releases for the following drug for the year 2010: Zolinza.	No records exist	0
A-2011-01044	Number of SAP releases for the following drug for the year 2010: Belinostat.	No records exist	0
A-2011-01045	Number of SAP releases for the following drug for the year 2010: Campath.	No records exist	0
A-2011-01046	Number of SAP releases for the following drug for the year 2010: Feraheme.	No records exist	0